Research Compound
Ipamorelin/CJC-1295 (no DAC) 5MG/5MG
Ipamorelin/CJC-1295 (no DAC) Blend combines two synthetic peptides for laboratory research.
Select Size
10mg
SKU: CP10
Batch: 202609-01-CP
$43.99
Ships today if ordered by 4PM EST
Est. Arrival: 09/18/2026
Volume Discounts
Qty: 1 - 4$43.99 each
Qty: 5 - 9$39.59 each(save $4.40)
Qty: 10+$35.19 each(save $8.80)
Quantity:
1
For Research Use Only. This product is intended for laboratory and scientific research purposes only. It is not a drug or dietary supplement and is not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease.
99%+ Purity
COA Included
Fast Shipping
USA Based
Product Details
Ipamorelin/CJC-1295 (no DAC) Blend combines two peptides:
Ipamorelin – Pentapeptide GHS-R agonist (Aib-His-D-2-Nal-D-Phe-Lys-NH2) with non-natural amino acids.
CJC-1295 (no DAC) – 29-amino acid tetrasubstituted GHRH analog (D-Ala2, Ala8, Leu15, Leu27) for proteolytic stability.
Combined lyophilized powder, soluble in sterile water or bacteriostatic water. Store at -20°C.
Disclaimer: For laboratory and research purposes only. Not intended for human consumption.
Frequently Asked Questions About Ipamorelin/CJC-1295 (no DAC) 5MG/5MG
Answers summarize published research and are provided for laboratory research purposes only.
Ipamorelin/CJC-1295 (no DAC) 5MG/5MG is a research blend of two synthetic peptides supplied together in one lyophilized vial. Ipamorelin is a pentapeptide ghrelin receptor agonist with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. CJC-1295 (no DAC) is a 29-amino acid analog of growth hormone releasing hormone with four substitutions, D-Ala2, Ala8, Leu15, and Leu27. Biotech Compounds supplies the blend for laboratory research.
Research studies describe the two components of the Ipamorelin/CJC-1295 (no DAC) blend as acting on separate pituitary receptors. Ipamorelin is a growth hormone secretagogue receptor agonist, and CJC-1295 (no DAC) is a GHRH receptor agonist. In animal models, researchers have reported that combining a secretagogue with a GHRH analog produced a larger growth hormone pulse than either agent alone, which is the rationale for pairing them in one vial.
The primary research area for the Ipamorelin/CJC-1295 (no DAC) blend is pituitary growth hormone secretion. Researchers have reported using paired secretagogue and GHRH analog protocols in rodent and pig studies to examine pulse amplitude, pulse timing, and downstream IGF-1 levels. The blend gives laboratories both classes at a fixed 5 mg to 5 mg ratio without weighing two separate powders.
Beyond growth hormone endpoints, animal studies of the Ipamorelin/CJC-1295 (no DAC) combination have examined body composition, lean mass, and bone density. Published research on CJC-1295 (no DAC) alone, also called Mod GRF 1-29, reported that the four amino acid substitutions were introduced to resist cleavage by the enzyme DPP-4. In research studies, Ipamorelin has been observed to release growth hormone with minimal effect on cortisol.
The evidence base for the Ipamorelin/CJC-1295 (no DAC) blend is preclinical. Each component has in vitro receptor data and animal model data, and each was studied separately in small early clinical programs that did not lead to approval. Ipamorelin/CJC-1295 (no DAC) 5MG/5MG is an investigational research reagent and is not an approved drug in any jurisdiction.
The Ipamorelin/CJC-1295 (no DAC) blend uses the short-acting form of CJC-1295. CJC-1295 W/ DAC adds a drug affinity complex, a lysine-linked maleimide group that researchers have reported binds serum albumin and extends the half-life from minutes to days. In research studies, the no DAC form produced discrete growth hormone pulses, while the DAC form produced a sustained elevation. Biotech Compounds sells CJC-1295 W/ DAC separately.
Ipamorelin/CJC-1295 (no DAC) 5MG/5MG is a combined lyophilized powder that is soluble in sterile water or Bacteriostatic Water. Researchers run the diluent slowly down the inside of the vial and swirl gently until both peptides dissolve. Shaking should be avoided. Bacteriostatic Water is the standard choice when the reconstituted blend will be sampled more than once in the laboratory.
Lyophilized Ipamorelin/CJC-1295 (no DAC) should be stored at minus 20 C, protected from light and moisture. Once reconstituted, the solution should be refrigerated at 2 to 8 C and kept away from light. Repeated freeze thaw cycles should be avoided. Researchers have reported that CJC-1295 (no DAC) has a short circulating half-life in animal models, so the reconstituted blend is generally used within a limited window.
Yes. Ipamorelin/CJC-1295 (no DAC) 5MG/5MG from Biotech Compounds is listed at 99 percent plus purity. Each lot is tested by an independent third-party laboratory, and the Certificate of Analysis for the blend is posted on the product page. Researchers can confirm the identity and purity of both peptides in the vial before use.
The product specifications for Ipamorelin/CJC-1295 (no DAC) 5MG/5MG list an approximate molecular weight of 4080.6 g/mol and a molecular formula of C190H301N53O47. Those values combine the pentapeptide Ipamorelin with the 29-amino acid CJC-1295 (no DAC) chain. The blend contains 5 mg of each peptide per vial as stated in the product name.
No. Ipamorelin/CJC-1295 (no DAC) 5MG/5MG is sold by Biotech Compounds strictly as a research material for laboratory research by qualified researchers and research organizations. Purchasers must be 21 years of age or older. The blend is not a drug or a dietary supplement, has not been approved by the FDA, and is not for human or animal consumption.
You May Also Like
